BioRad.io Podcast Series

Each month, join Kashef Qaadri, a biologist turned bioinformatician, as he interviews guests exploring real-world research informatics challenges through use-cases, providing insights and strategies for integrating and analyzing complex data that are driving biopharma research and development.

Listen on Apple Podcasts

Episode 19: Reimagining Cancer Drug Development

In this episode, we discuss the way cancer drug development can be reimagined using AI and machine learning. Traditional drug development faces a high failure rate, highlighting the importance of understanding a drug’s mechanism of action to improve success rates. AI and computational models that analyze data from various modalities, such as genomics and clinical information, can identify novel targets and enhance precision medicine. Advancements in data availability, especially in the clinic, and a deeper biological understanding are fundamental to revolutionize future drug discovery.
Guest: David Li, Co-Founder and CEO, Meliora Therapeutics, Inc.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 32:11 | File size: 46.6 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 18: The Future of Microbial Drug Discovery

Microbial drug discovery holds immense promise in revolutionizing healthcare. Although fungi and other microbes have long been a source of natural compounds with therapeutic potential, advancements in technology have made the search for new candidates easier than ever. By harnessing the power of artificial intelligence and machine learning, researchers can rapidly explore the rich genetic diversity of fungi and predict therapeutic potential. This convergence of science and technology will undoubtedly drive the future of microbial drug discovery, leading to the development of groundbreaking treatments for various diseases.
Guest: Karen Wong, PhD, Computational Biologist, Hexagon Bio

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 31:19 | File size: 45.3 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 17: Biomarker Identification for Early Disease Detection

When diseases such as cancers are detected in their early stages, before they have spread, the overall survival rate is significantly higher than when diagnosed in later stages. Developing biomarker tests that detect early-stage tumors is complex and difficult, but quite rewarding, leading to improved characterization, treatment, and management of cancer. Determining which types of data (genomic, proteomic, etc.) are most informative is a major challenge requiring extensive research and discovery. In this episode, we discuss the need for early detection tools, methods for developing them, and some of the informatics challenges, including algorithm and model development, handling large volumes of data from multiple sources, and data integration.
Guest: Peter Meintjes, PhD, CEO, Pacific Edge, Ltd.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 30:15 | File size: 36.5 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 16: Digital Precision Medicine

Precision medicine is a multifaceted approach to designing and delivering individualized patient treatments. Using multi-omic, environmental, lifestyle, and other data, researchers aim to more accurately develop treatment and prevention strategies tailored to each unique patient. The promise of precision medicine is huge, but it also creates new challenges around data capture, storage, computation, and creation of algorithms for prediction and analysis. In this episode, we discuss the evolution of precision medicine and some ways these challenges are and can be addressed, including blockchain, remote patient monitoring, and strategic data integration.
Guest: Kumar Bala, Former Head of Digitalomics Strategy, Oracle

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 30:41 | File size: 37.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 15: Optimizing Drug Target Identification through Artificial Intelligence

Traditionally, drug targets are found by scouring scientific publications for insights into molecular pathways or known causative genetic variants, linked to disease. The failure rate of drug candidates in the clinic, even in relatively late-stage clinical trials, is quite high and is extremely costly. Fundamentally, finding better targets will lead to development of better medicines. In this episode, we discuss how artificial intelligence (AI) and the increasing availability of complex biological datasets can be leveraged to identify molecular targets. Machine learning models trained on large amounts of data allow researchers to differentiate between states or conditions more specifically to predict disease-relevant targets.
Guest: Avantika Lal, PhD, Senior Genomic Data Scientist, insitro

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 31:07 | File size: 38.0 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 14: The Rise of Digital Therapeutics

Digital therapeutics are software-driven, evidence-based products used to prevent, manage, or treat a medical disease or disorder. Digital therapeutics enable patients to be more aware of, and play a more active role in, managing their health and can improve access for patients for whom visiting a clinician is challenging. This significantly improves health outcomes and reduces healthcare demands as compared to more traditional interventions alone. Digital therapeutics are expected to grow dramatically over the next few years, but significant challenges around regulation and adoption remain. Listen in as we discuss the current state of the industry and where this technology may take us in the future.
Guest: Emily Lewis, MS, CCRP, Global Digital Transformation Lead, Neurology, UCB

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 30:30 | File size: 36.8 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 13: The Realities of Personalized Medicine

Personalized medicine is critical to the future of our healthcare and wellness. Using vast sets of clinical, genomic, proteomic, and other patient data, potentially lifechanging treatments can be discovered and delivered to patients. However, implementation of personalized medicine faces unique challenges, partly because it is focused on individuals, each with their own unique genetics and history, whereas clinical trials tend to average across populations. What changes are needed for personalized medicine to truly become a reality? In this episode, we discuss some of the biggest obstacles and what is needed to catalyze advances in personalized medicine.
Guest: Rong Chen, PhD, Assistant Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 29:05 | File size: 34.9 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 12: The Future of Data Management

Various high-throughput technologies have triggered an upsurge in scientific data generation and consumption. These advances have, in turn, prompted research informaticians to explore novel approaches to procuring and operationalizing research data, adding value. Data fabric is an emerging data architecture pattern, which connects disparate data sources in a single, consolidated environment. Data fabric allows business applications, end users, data management, and analysis tools to securely access and process data stored across locations, enabling them to gain a complete picture of data across the discovery pipeline. In this episode, we discuss how data fabrics differ from data lakes and data hubs, and whether they will make these other solutions obsolete.
Guest: Sanjay Joshi, Global CIO, Healthcare and Life Sciences, Tanium Inc.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 27:51 | File size: 39.9 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 11: The Synthetic Biology Revolution

Synthetic biology is the design, testing, and construction of new, standardized biological parts and devices, and programming them to do something productive. Significant medical breakthroughs are already happening as a result of advances in synthetic biology. From antiviral treatment and immune cell engineering to biomonitoring, the applications of synthetic biology are endless, creating new opportunities for innovative informatics. In this episode, we discuss revolutionary applications of synthetic biology in biopharma.
Guest: Mark Charbonneau, PhD, Director and Head of Quantitative Biology, Synlogic

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 30:02 | File size: 40.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 10: Next-Generation Therapeutic Antibody Discovery

Over the past three decades, since the first monoclonal antibody was approved for clinical use in the U.S., antibody techniques and technologies have advanced radically. However, the supporting informatics have evolved at a much slower pace. There are significant informatic challenges throughout the research process, from concept to regulatory submission. How can a holistic informatics strategy support gaining clearer insights into scientific operations, make smarter decisions about their campaigns, and ultimately bring therapeutics to the clinic faster? Guest: Colby Souders, PhD, Chief Scientific Officer, Abveris

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 33:14 | File size: 40.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 9: The Future of Open Access Research Data

Data liquidity, the ability of data to flow easily and securely, provides tremendous value for biopharma researchers. Open access is paving the way for increased collaboration and discovery. However, additional initiatives are needed to further promote the management and sharing of scientific data and ensure that information is quickly available to researchers. This episode highlights the needs, solutions, and challenges of ensuring interoperability of research data throughout the data lifecycle.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 33:14 | File size: 40.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 8: Data Sharing and Collaboration

Increasingly, pharma is looking at partnerships and collaborations to increase the velocity of drug discovery and development. Common data sharing platforms are not built to meet lab-specific requirements. In addition to discussing the necessity of simple and secure collaboration, listeners will learn about the dangers of not using proper tools.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 33:14 | File size: 40.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Episode 7: Data Standardization

As biopharma research and development continues to transform digitally, the industry as a whole struggles with guidance on how data and relevant metadata are captured, managed, and shared. Typically experimental data are siloed, stored in varying formats, difficult to retrieve and share. However, data needs to be better managed to be more collaborative and interoperable. How can data standardization help forge a path so that systems can find and access data with minimal human intervention?

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 28:29 | File size: 32.8 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 6: Genomic Data Disparities

Sequencing is used to identify novel drug targets and genetically stratifying clinical trial patients, improving the power of precision medicine. However, the global disparity of genomic technologies is increasing. How will this affect drug development, particularly for non-European ethnicities? Why is it important to have a global context for targeted therapies?

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 28:13 | File size: 00.0 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 5: Lab of the Future (LoTF)

Life science companies are looking to modernize their research environments and build the Lab of the Future. From robots automating experiments to more sophisticated smart machines that communicate with users, how will the Lab of the Future accelerate research and ensure the accuracy and efficiency of experiments, reducing the risk of human error and improving safety?

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 28:47 | File size: 33.1 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 4: Active Learning in Drug Discovery

What are the theories, algorithmic principles, and limitations of active learning? What are some current applications of active learning within BioPharma drug screening and optimization? How can active learning accelerate multi-dimensional drug discovery? Find out here.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 28:03 | File size: 32.3 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 3: Next-Generation Data Integration, Visualization, and Exploration

What is the vision of interactive data exploration beyond enriching visualizations and facilitating the integration of data? Within the context of research, what are the challenges and opportunities in building next-generation visual analytics? Listen to find out.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 29:00 | File size: 33.4 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 2: The Realities of AI/ML

Artificial Intelligence (AI) and Machine Learning (ML) are big topics getting lots of attention within BioPharma. What is the role of AI/ML in genomics? How can we take advantage of these advanced methods to exploit complex data, allowing elusive patterns to be identified for drug discovery? How can AI be used to advance research and development “from data to knowledge?” How can we separate the hype of AI/ML from reality? Find out here.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 29:33 | File size: 34.0 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Episode 1: Moving to the Cloud

Why are research organizations moving to the Cloud? Learn why they decided to initiate the move, what issues they’ve tackled, what their biggest challenges were, and where they’re going next.

Listen Here

Listen on Apple Podcasts Download podcast
Duration: 21:50 | File size: 25.2 MB | Recommended browsers: Google Chrome, Mozilla Firefox

Read the article for this podcast

Previous post

NalaGenetics Moves Pharmacogenomics from the Bench to the Clinic using qPCR: An Interview with Astrid Irwanto, Co-Founder and COO

Next post

CAR T-Cell Therapy and the Cytokine Storm: The Balancing Act at the Center of Next-Generation Cancer Therapies